Delivery Order SPE2DB24D2205-SPE2DB24FDXXT
Award Date
8/5/24
Potential Completion Date
8/6/24
Potential Value
$7.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The award has a ceiling value of $5,358.46 and a period of performance through August 19, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $2,557.92 and a completion date of September 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies without any set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $6,510.68, is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $1,924.84 and runs through September 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of pharmaceutical and medical supplies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 75 MG TABLET 60S. The order has a ceiling value of $1,175.88 and a completion date of September 9, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. As a leading supplier of pharmaceutical products and medical supplies to the federal government, AmerisourceBergen has been awarded numerous...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,322.79 and is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. It is a firm fixed-price delivery order contract with a completion date of December 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The order is valued at $6,104.90 and has a delivery deadline of October 15, 2024. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of the pharmaceutical product BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $1,188.77 and a completion date of May 13, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leverages its...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 100 MG TABLET 60S. The contract has a ceiling value of $2,284.22 and an ultimate completion date of February 21, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a specialty medication, with a ceiling value of $5,629.68 and a completion date of December 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...